Cargando…
Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer
OBJECTIVES: In lung cancer, surgery remains the most curative treatment and limited resection is beneficial for patients with low cardiopulmonary function and low malignancy tumors. However, there are no biomarkers of low malignancy to select candidates for limited resection without compromising the...
Autores principales: | Morimoto, Hirofumi, Hida, Yasuhiro, Maishi, Nako, Nishihara, Hiroshi, Hatanaka, Yutaka, Li, Cong, Matsuno, Yoshihiro, Nakamura, Toru, Hirano, Satoshi, Hida, Kyoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088962/ https://www.ncbi.nlm.nih.gov/pubmed/33709550 http://dx.doi.org/10.1111/1759-7714.13907 |
Ejemplares similares
-
Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy
por: Cong, Li, et al.
Publicado: (2021) -
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell‐specific liposomal siRNA delivery system
por: Maishi, Nako, et al.
Publicado: (2022) -
Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan
por: Maishi, Nako, et al.
Publicado: (2016) -
Contribution of Tumor Endothelial Cells in Cancer Progression
por: Hida, Kyoko, et al.
Publicado: (2018) -
Tumor endothelial cells accelerate tumor metastasis
por: Maishi, Nako, et al.
Publicado: (2017)